KRAS and rectal cancer: In a former study our results demonstrated the reliable detection of KRAS mutation status for therapeutic decisions in pre-therapeutic biopsies as well as in post-therapeutic residual tumor tissue in patients with locally advanced rectal cancer who were treated preoperatively with chemoradiotherapy.